Business
Biotech Firm Amyris Hit with $881M Suit over Cannabinoid IP
By
Willis Jacobson
Sep 17, 2020
Sep 17, 2020
A cannabinoid manufacturer has sued biotech company Amyris for $881M, amid a fraught 18-months relationship between the companies. Among other allegations, the lawsuit claims Amyris used the partnership to artificially inflate its own value and then leveraged the plaintiff’s trade...
This content is FREE for registered users.
To view this content you need to register as a Weedweek member.
If you are already a member please login below.
sponsored
The Best 420 Deals in Los Angeles for 2024
Are you looking for the best cannabis discounts and events for April.20.2024 in Los Angeles? Today we’re putting a spotlight on the LAX Cannabis Club dispensary, which is conveniently located a short drive from the LAX airport. Therefore, it's the...
pro
What should Calif. do about hemp?
Last week, the California State Assembly’s Business and Professions Committee unanimously cleared a bill that would require intoxicating, hemp-derived products to be regulated much like licensed cannabis and sold in dispensaries. The 18-0 vote indicates lawmaker interest in addressing an...
california
“We will strike, period!” Eaze workers escalate walkout threat
Eaze drivers stepped up their rhetoric about poor pay and treatment, as their threat of a 4/20 strike looms.At an event in Los Angeles Wednesday, Eaze workers with the United Food and Commercial Workers Union (UFCW) spoke about struggling to...
